Maybe Bal management were too busy deciding what colour crayons to use on their graphs and charts for the next investors day to notice the change in CBEC rules.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025